Journal of Psychoactive Drugs
2024
Nancy A Haug, Richa Wadekar, Rachel Barry et al.
Ecstasy/Molly/MDMA is a widely used substance often taken in combination with other drugs in different contexts. The current study assessed ecstasy use patterns, concurrent substance use and the context of ecstasy use among an international sample of adults (N = 1,732). Participants were 87% white, 81% male, 42% college educated, 72% employed, with a mean age of 25.7 (SD = 8.3). Using the...
Clinical Psychology & Psychotherapy
July 2, 2023
Aileen Kucsera, Trisha Suppes, Nancy A Haug
27 citations
Abstract Introduction This study explored the current knowledge, attitudes, and clinical practices regarding psychedelics among mental health professionals in California, where state legislation to decriminalize psychedelics has been proposed. Method Two hundred thirty‐seven mental health providers (74% female; mean age 54; 83% White; 46% psychologists) completed a 37‐item online survey between...
Addictive behaviors
2023
James E Sottile, Kathryn S Macia, Robert E Wickham et al.
MDMA/Ecstasy motives differ from those of other substances such as alcohol, cannabis, and methamphetamine. Previous literature on alcohol and cannabis use identified social, expansion, enhancement, coping, and conformism as primary motives for use. MDMA/Ecstasy users also report using the drug for increases in self-awareness and energy. The development of an MDMA/Ecstasy use motives assessment...
Journal of psychopharmacology (Oxford, England)
February 1, 2021
Rebecca L Rothberg, Nour Azhari, Nancy A Haug et al.
95 citations
Sub-anesthetic ketamine administration may be helpful for substance use disorders. Converging evidence suggests that the efficacy of ketamine for certain conditions may implicate a subset of its psychoactive effects. The aim of this analysis is to evaluate whether the mystical-type effects of ketamine are critical for clinical efficacy in alcohol-dependent individuals. In this secondary...